Your browser doesn't support javascript.
loading
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial.
Mittendorf, Elizabeth A; Zhang, Hong; Barrios, Carlos H; Saji, Shigehira; Jung, Kyung Hae; Hegg, Roberto; Koehler, Andreas; Sohn, Joohyuk; Iwata, Hiroji; Telli, Melinda L; Ferrario, Cristiano; Punie, Kevin; Penault-Llorca, Frédérique; Patel, Shilpen; Duc, Anh Nguyen; Liste-Hermoso, Mario; Maiya, Vidya; Molinero, Luciana; Chui, Stephen Y; Harbeck, Nadia.
Afiliación
  • Mittendorf EA; Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. Electronic address: emittendorf@bwh.harvard.edu.
  • Zhang H; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Barrios CH; Centro de Pesquisa em Oncologia, Hospital São Lucas, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil.
  • Saji S; Fukushima Medical University, Fukushima, Japan.
  • Jung KH; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Hegg R; University of São Paulo, São Paulo, Brazil.
  • Koehler A; Gemeinschaftspraxis für Haematologie und Onkologie Langen, Langen, Germany.
  • Sohn J; Yonsei Cancer Center, Yonsei University Health System, Seoul, South Korea.
  • Iwata H; Aichi Cancer Center Hospital, Nagoya, Japan.
  • Telli ML; School of Medicine, Stanford University, Stanford, CA, USA.
  • Ferrario C; Jewish General Hospital-McGill University, Montréal, QC, Canada.
  • Punie K; Department of General Medical Oncology and Multidisciplinary Breast Centre, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
  • Penault-Llorca F; Department of Biopathology, Centre Jean Perrin and University Clermont Auvergne/INSERM U1240, Clermont-Ferrand, France.
  • Patel S; Genentech, South San Francisco, CA, USA.
  • Duc AN; F Hoffmann-La Roche, Basel, Switzerland.
  • Liste-Hermoso M; F Hoffmann-La Roche, Basel, Switzerland.
  • Maiya V; Genentech, South San Francisco, CA, USA.
  • Molinero L; Genentech, South San Francisco, CA, USA.
  • Chui SY; Genentech, South San Francisco, CA, USA.
  • Harbeck N; Breast Center, Department of Gynecology and Obstetrics and Comprehensive Cancer Center of the Ludwig-Maximilians-University, Munich, Germany.
Lancet ; 396(10257): 1090-1100, 2020 10 10.
Article en En | MEDLINE | ID: mdl-32966830
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Albúminas / Anticuerpos Monoclonales Humanizados / Neoplasias de la Mama Triple Negativas / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Middle aged Idioma: En Revista: Lancet Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Albúminas / Anticuerpos Monoclonales Humanizados / Neoplasias de la Mama Triple Negativas / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Middle aged Idioma: En Revista: Lancet Año: 2020 Tipo del documento: Article